Erasca, Inc. - Common Stock, $0.0001 par value per share (ERAS)

Historical Holders from Q3 2021 to Q1 2025

Symbol: ERAS on Nasdaq
Type / Class: Equity / COM
Shares outstanding: 280M
All holders as of December 31, 2024: Q4 2024
Shares, excl. options: 231M
Holdings value: $579M
% of all portfolios: 0.002%
Grand Portfolio weight change: 0%
Number of holders: 144
Number of buys: 72
Number of sells: -51
Average Value change %: +0%
Average buys %: +0%
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Erasca, Inc. - Common Stock, $0.0001 par value per share (ERAS)

Filer	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC	4.4%	$18.1M		12.3M		SUVRETTA CAPITAL MANAGEMENT, LLC	Dec 31, 2024
NOVARTIS PHARMA AG	4.4%	$18.1M		12.3M		Novartis Pharma AG	Dec 31, 2024

Showing 1 to 2 of 2 entries

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q1	298K	$408K	-$6.61K			$1.37	4
2024 Q4	231M	$579M	-$3.89M	163K	27.4K	$2.51	144
2024 Q3	232M	$633M	+$46.9M	318K	78.4K	$2.73	130
2024 Q2	204M	$480M	+$312M	336K	7.32K	$2.36	124
2024 Q1	72.7M	$150M	+$6.87M	82.6K	14.6K	$2.06	105
2023 Q4	69.2M	$148M	-$3.99M	11.1K	9.37K	$2.13	115
2023 Q3	71.3M	$140M	-$6.33M	1.18K	788	$1.97	106
2023 Q2	74.3M	$205M	-$10.9M	552	552	$2.76	109
2023 Q1	78M	$235M	-$11.5M	40.9K	8.43K	$3.01	114
2022 Q4	79.8M	$344M	+$2.8M	7.76K	96.5K	$4.31	104
2022 Q3	80.5M	$628M	+$33.8M		16K	$7.80	85
2022 Q2	76.9M	$428M	+$22M			$5.57	86
2022 Q1	72.8M	$626M	+$45.2M			$8.60	79
2021 Q4	63.7M	$988M	+$64.7M			$15.58	63
2021 Q3	44.1M	$919M	+$919M			$21.22	53